Using the model output, HSP global prevalence was estimated to be 3.6 per 100,000 (3.0–4.3), which was obtained by combining SPG4 or SPG11 global prevalence with their respective fraction of HSP prevalence from Omidvar et al. [1]. This evidence concerns the gene SPAST and hereditary spastic paraplegia.